Boston Scientific ( (BSX) ) has released its Q4 earnings. Here is a breakdown of the information Boston Scientific presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Boston Scientific is a leading global medical technology company that provides a wide range of high-performance medical devices and therapies for diagnosing and treating complex medical conditions across various fields such as cardiovascular, respiratory, digestive, neurological, and urological diseases.
Boston Scientific reported robust financial growth for the fourth quarter and the full year of 2024, with net sales reaching $4.561 billion for the fourth quarter, marking a 22.4% increase on a reported basis. For the full year, net sales amounted to $16.747 billion, representing a growth of 17.6%. GAAP net income for the fourth quarter stood at $566 million, translating to $0.38 per share, while adjusted earnings per share were $0.70, reflecting a significant year-over-year improvement.
Key financial highlights for Boston Scientific in 2024 include substantial growth in both the MedSurg and Cardiovascular segments, with Cardiovascular reporting a notable 28.8% increase in net sales. Regionally, the United States experienced a strong 30.7% growth in reported net sales. The company’s innovative portfolio, including successful launches like the FARAPULSE™ Pulsed Field Ablation System, and strategic acquisitions such as Axonics, Inc., and Cortex, Inc., contributed to this performance.
Looking ahead, Boston Scientific’s management remains optimistic, projecting continued growth into 2025 with expected net sales increases ranging from 12.5% to 14.5% on a reported basis for the full year. The company aims to build on its strong foundation and continue transforming patient lives with its innovative solutions while navigating the evolving healthcare landscape.
